Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron
Abstract The recently identified, globally predominant SARS-CoV-2 Omicron variant (BA.1) is highly transmissible, even in fully vaccinated individuals, and causes attenuated disease compared with other major viral variants recognized to date1–7. The Omicron spike (S) protein, with an unusually large number of mutations, is considered the major driver of these phenotypes3,8. We generated chimeric recombinant SARS-CoV-2 encoding the S gene of Omicron in the backbone of an ancestral SARS-CoV-2 isolate and compared this virus with the naturally circulating Omicron variant. The Omicron S-bearing virus robustly escapes vaccine-induced humoral immunity, mainly due to mutations in the receptor-binding motif (RBM), yet unlike naturally occurring Omicron, efficiently replicates in cell lines and primary-like distal lung cells. In K18-hACE2 mice, while Omicron causes mild, non-fatal infection, the Omicron S-carrying virus inflicts severe disease with a mortality rate of 80%. This indicates that while the vaccine escape of Omicron is defined by mutations in S, major determinants of viral pathogenicity reside outside of S..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 12. Jan. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Da-Yuan [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2022.10.13.512134 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI037580256 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI037580256 | ||
| 003 | DE-627 | ||
| 005 | 20230429090353.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221017s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2022.10.13.512134 |2 doi | |
| 035 | |a (DE-627)XBI037580256 | ||
| 035 | |a (biorXiv)10.1101/2022.10.13.512134 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Da-Yuan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The recently identified, globally predominant SARS-CoV-2 Omicron variant (BA.1) is highly transmissible, even in fully vaccinated individuals, and causes attenuated disease compared with other major viral variants recognized to date1–7. The Omicron spike (S) protein, with an unusually large number of mutations, is considered the major driver of these phenotypes3,8. We generated chimeric recombinant SARS-CoV-2 encoding the S gene of Omicron in the backbone of an ancestral SARS-CoV-2 isolate and compared this virus with the naturally circulating Omicron variant. The Omicron S-bearing virus robustly escapes vaccine-induced humoral immunity, mainly due to mutations in the receptor-binding motif (RBM), yet unlike naturally occurring Omicron, efficiently replicates in cell lines and primary-like distal lung cells. In K18-hACE2 mice, while Omicron causes mild, non-fatal infection, the Omicron S-carrying virus inflicts severe disease with a mortality rate of 80%. This indicates that while the vaccine escape of Omicron is defined by mutations in S, major determinants of viral pathogenicity reside outside of S. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Kenney, Devin |4 aut | |
| 700 | 1 | |a Chin, Chue Vin |4 aut | |
| 700 | 1 | |a Tavares, Alexander H. |4 aut | |
| 700 | 1 | |a Khan, Nazimuddin |4 aut | |
| 700 | 1 | |a Conway, Hasahn L. |4 aut | |
| 700 | 1 | |a Liu, GuanQun |4 aut | |
| 700 | 1 | |a Choudhary, Manish C. |4 aut | |
| 700 | 1 | |a Gertje, Hans P. |4 aut | |
| 700 | 1 | |a O’Connell, Aoife K. |4 aut | |
| 700 | 1 | |a Kotton, Darrell N. |4 aut | |
| 700 | 1 | |a Herrmann, Alexandra |4 aut | |
| 700 | 1 | |a Ensser, Armin |0 (orcid)0000-0001-8873-3863 |4 aut | |
| 700 | 1 | |a Connor, John H. |0 (orcid)0000-0002-8867-7256 |4 aut | |
| 700 | 1 | |a Bosmann, Markus |4 aut | |
| 700 | 1 | |a Li, Jonathan Z. |4 aut | |
| 700 | 1 | |a Gack, Michaela U. |4 aut | |
| 700 | 1 | |a Baker, Susan C. |0 (orcid)0000-0001-6485-8143 |4 aut | |
| 700 | 1 | |a Kirchdoerfer, Robert N. |4 aut | |
| 700 | 1 | |a Kataria, Yachana |0 (orcid)0000-0002-6249-7134 |4 aut | |
| 700 | 1 | |a Crossland, Nicholas A. |0 (orcid)0000-0003-3873-9188 |4 aut | |
| 700 | 1 | |a Douam, Florian |4 aut | |
| 700 | 1 | |a Saeed, Mohsan |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 12. Jan. |
| 773 | 1 | 8 | |g year:2023 |g day:12 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2022.10.13.512134 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 12 |c 01 | ||